Furthermore, co‐injection of BMDMsPRDX1‐KO or RAW264.7PRDX1‐KD cells inhibited syngeneic tumor growth by enhancing CD8+ T‐cell cytotoxicity and secretion of TNF‐α and GzmB. The gene discussed is CD8A; the disease is neoplasm.